Effect of calcitonin and hexestrol on urinary excretion of hydroxyproline in a patient with prostatic cancer and bone metastases.
D000135:Acid Phosphatase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001859:Bone Neoplasms / Q000097:blood / Q000201:enzymology / Q000652:urine*; D002116:Calcitonin / Q000008:administration & dosage / Q000494:pharmacology*; D002118:Calcium / Q000097:blood / Q000652:urine; D006589:Hexestrol / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D006909:Hydroxyproline / Q000652:urine*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010758:Phosphorus / Q000652:urine; D011471:Prostatic Neoplasms / Q000097:blood / Q000201:enzymology / Q000652:urine*
D006589:Hexestrol; D010758:Phosphorus; D002116:Calcitonin; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D006909:Hydroxyproline; D002118:Calcium